Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer.
Ontology highlight
ABSTRACT: Current developments in the treatment of genitourinary tumors underline the unmet clinical need for biomarkers to improve decision-making in a challenging clinical setting. The detection of circulating tumor cells (CTCs) has become one of the most exciting and important new approaches to identifying biomarkers at different stages of disease in a non-invasive way. Potential applications of CTCs include monitoring treatment efficacy and early detection of progression, selecting tailored therapies, as well as saving treatment costs. However, despite the promising implementation of CTCs in a clinical scenario, the isolation and characterization of these cells for molecular studies remain expensive with contemporary platforms, and significant technical challenges still need to be overcome. This
SUBMITTER: Cimadamore A
PROVIDER: S-EPMC7348874 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA